Insulin glargine and lixisenatide Subcutaneous and Zoster Vaccine (Recombinant)
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Zoster Vaccine (Recombinant) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: zoster vaccine, inactivated
Brand name: Shingrix
Synonyms: Zoster vaccine (inactivated)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Zoster vaccine inactivated
- Insulin glargine and lixisenatide Subcutaneous-Zoster vaccine live
- Insulin glargine and lixisenatide Subcutaneous-Zoster vaccine recombinant, adjuvanted Intramuscular
- Insulin glargine and lixisenatide Subcutaneous-Zoster vaccine, live Subcutaneous
- Insulin glargine and lixisenatide Subcutaneous-Zostrix
- Insulin glargine and lixisenatide Subcutaneous-Zostrix (Capsaicin Cream, Gel, Liquid, and Lotion)
- Zoster Vaccine (Recombinant)-Insulin glargine, recombinant Subcutaneous
- Zoster Vaccine (Recombinant)-Insulin glulisine
- Zoster Vaccine (Recombinant)-Insulin Glulisine (Cartridges and Pens)
- Zoster Vaccine (Recombinant)-Insulin Glulisine (Vials)
- Zoster Vaccine (Recombinant)-Insulin glulisine Subcutaneous
- Zoster Vaccine (Recombinant)-Insulin human inhaled Inhalation